Legend Biotech LEGN
NASDAQ LEGN
$18.57 -0.75 (-3.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Cash & Current Investments (2019 - 2026)

Updated

Legend Biotech (LEGN) posted Cash & Current Investments of $964.6 million for Q2 2026, down 0.3% from $967.6 million a year earlier but up 15.6% from the prior quarter.

Analysis

Legend Biotech (LEGN) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Legend Biotech's Cash & Current Investments came in at $948.6 million, down 15.5% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
  • In prior years, Legend Biotech's Cash & Current Investments was $1.12 billion in FY2024 (-14.8%), $1.32 billion in FY2023 (+56.6%), $841.32 million in FY2022 (-2.5%) and $863.31 million in FY2021 (+55.3%).
  • Quarterly Cash & Current Investments has run from a low of $556.04 million in Q3 2021 to a high of $1.34 billion in Q2 2023 over five years.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last nine quarters, with an average decline of 13.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2022, with growth of 85.5%; the weakest was Q2 2025, with a decline of 23.1%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $834.6 million (Q1 2026), $948.6 million (Q4 2025) and $992.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Legend Biotech 3.42 Bn -317.56 Mn 251.50 Mn 964.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 964.60 Mn
Mar 31, 2026 834.60 Mn
Dec 31, 2025 948.60 Mn
Sep 30, 2025 992.59 Mn
Jun 30, 2025 967.60 Mn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 1.12 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.26 Bn
Mar 31, 2024 1.16 Bn
Dec 31, 2023 1.32 Bn
Sep 30, 2023 1.25 Bn
Jun 30, 2023 1.34 Bn
Mar 31, 2023 674.43 Mn
Dec 31, 2022 786.03 Mn
Sep 30, 2022 1.03 Bn
Jun 30, 2022 788.98 Mn
Mar 31, 2022 672.19 Mn
Dec 31, 2021 693.64 Mn
Sep 30, 2021 556.04 Mn
API Access

Legend Biotech Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LEGN&period=max&api_key=YOUR_API_KEY